Group 5E: HER2-negative Breast Cancer; Biomarkers; Racial Differences

Oral Abstract #1017: Racial differences in genomic profiles and targeted treatment use in ER+ HER2- metastatic breast cancer.

Poster #1039: Differential genomic profiling of the progesterone receptor (PR) negative and estrogen receptor (ER) low metastatic breast cancer subtypes through circulating tumor DNA: A TNBC-like disease subtype?


Jun 13 2024


2:00 pm - 3:30 pm

Zoom Webinar